Is Viridian Therapeutics, Inc. (VRDN) a Buy, Sell, or Hold?
NASDAQ : VRDN
Viridian Therapeutics, Inc. — Earnings Estimates
$20.84 USD
$1.53 (7.92%)
- Volume
- 2.17M
- Average Volume
- 2.56M
- Market Capitalization
- $1.88B
- P/E Ratio
- -5.99
- Dividend Yield
- 0.00%
- Price Target
- $38.50
- Year High
- $34.29
- Year Low
- $13.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.15
Annual earnings financials
VRDN financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
VRDN Estimated and Actual Revenue by Quarter
VRDN Estimated and Actual EPS by Quarter
VRDN Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2028-12-31 | 6 | -309.28M | -177.91M | -237.11M | -309.28M | -177.91M | -237.11M |
| 2028-09-30 | 3 | -260.89M | -150.07M | -200.01M | -260.89M | -150.07M | -200.01M |
| 2028-06-30 | 5 | -216.22M | -124.38M | -165.77M | -216.22M | -124.38M | -165.77M |
| 2028-03-31 | 3 | -162.43M | -93.44M | -124.53M | -162.43M | -93.44M | -124.53M |
| 2027-12-31 | 7 | -191.18M | -109.97M | -146.57M | -191.18M | -109.97M | -146.57M |
| 2027-09-30 | 4 | -124.62M | -71.69M | -95.54M | -124.62M | -71.69M | -95.54M |
VRDN Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2028-12-31 | 6 | 30.65M | 63.34M | 45.38M | 19.03B | 33.08B | 25.36B |
| 2028-09-30 | 3 | 16.38M | 33.85M | 24.25M | 16.05B | 27.9B | 21.39B |
| 2028-06-30 | 5 | 3.31M | 6.85M | 4.91M | 13.3B | 23.12B | 17.73B |
| 2028-03-31 | 3 | -28.59M | -13.83M | -20.48M | 9.99B | 17.37B | 13.32B |
| 2027-12-31 | 7 | -16.9M | -8.18M | -12.11M | 11.76B | 20.45B | 15.67B |
| 2027-09-30 | 4 | -62.16M | -30.08M | -44.54M | 7.67B | 13.33B | 10.22B |
VRDN Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2028-12-31 | 6 | 177.91M | 309.28M | 237.11M | 7 | 0.29988 | 0.61967 | 0.444 |
| 2028-09-30 | 3 | 150.07M | 260.89M | 200.01M | 4 | 0.16027 | 0.33119 | 0.2373 |
| 2028-06-30 | 5 | 124.38M | 216.22M | 165.77M | 6 | 0.03241938 | 0.0669913 | 0.048 |
| 2028-03-31 | 3 | 93.44M | 162.43M | 124.53M | 4 | -0.27969 | -0.13535 | -0.2004 |
| 2027-12-31 | 7 | 109.97M | 191.18M | 146.57M | 6 | -0.16534 | -0.08001508 | -0.11847 |
| 2027-09-30 | 4 | 71.69M | 124.62M | 95.54M | 3 | -0.60818 | -0.29432 | -0.43577 |